Key Takeaways
- Globally, an estimated 970 million people were living with a mental disorder in 2019, with anxiety and depressive disorders being the most common
- In the US, 22.8% of adults experienced any mental illness (AMI) in 2022, equating to 59.3 million people aged 18 and older
- Depression affected 280 million people worldwide in 2019, making it the leading cause of disability globally
- In the US, women are 2 times more likely than men to experience depression, with 10.5% vs 5.5% past-year prevalence in 2022 NSDUH data
- Among US adults, those aged 18-25 had the highest AMI rate at 36.2% in 2022
- Black or African American adults in US had 12-month depression prevalence of 6.4% vs 9.1% non-Hispanic white in 2022
- Mental illness costs the US $282 billion annually in lost earnings per 2023 Milken Institute
- Globally, depression and anxiety caused 49 million years lived with disability in 2019
- US workplace productivity loss from depression $44 billion yearly in 2023 estimates
- Only 28% of people with psychosis receive treatment globally per 2023 WHO
- In US, 50.6% of adults with AMI received treatment in 2022 per NSDUH
- Antidepressant use rose 65% globally 2006-2020, peaking post-COVID 2023 IQVIA
- Post-COVID telehealth parity laws in 40 US states boosted access 15% 2023
- Social media use >3hrs/day linked to 27% higher depression risk youth 2023 JAMA
- Climate anxiety affects 59% young people globally per 2023 Lancet survey
Mental health conditions affect billions globally, yet most people lack proper treatment.
Demographic Breakdowns
Demographic Breakdowns Interpretation
Economic and Social Impacts
Economic and Social Impacts Interpretation
Emerging Trends
Emerging Trends Interpretation
Prevalence Rates
Prevalence Rates Interpretation
Treatment Statistics
Treatment Statistics Interpretation
Sources & References
- Reference 1WHOwho.intVisit source
- Reference 2SAMHSAsamhsa.govVisit source
- Reference 3THELANCETthelancet.comVisit source
- Reference 4GOVgov.ukVisit source
- Reference 5NIMHnimh.nih.govVisit source
- Reference 6ANADanad.orgVisit source
- Reference 7ABSabs.gov.auVisit source
- Reference 8PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 9CDCcdc.govVisit source
- Reference 10ECec.europa.euVisit source
- Reference 11STATCANwww150.statcan.gc.caVisit source
- Reference 12MHLWmhlw.go.jpVisit source
- Reference 13NCBIncbi.nlm.nih.govVisit source
- Reference 14JAMANETWORKjamanetwork.comVisit source
- Reference 15ALZINTalzint.orgVisit source
- Reference 16SLEEPFOUNDATIONsleepfoundation.orgVisit source
- Reference 17GALLUPgallup.comVisit source
- Reference 18AIHWaihw.gov.auVisit source
- Reference 19PTSDptsd.va.govVisit source
- Reference 20HEALTHYMINDSNETWORKhealthymindsnetwork.orgVisit source
- Reference 21THETREVORPROJECTthetrevorproject.orgVisit source
- Reference 22MENTALHEALTHmentalhealth.org.ukVisit source
- Reference 23UNHCRunhcr.orgVisit source
- Reference 24BJSbjs.ojp.govVisit source
- Reference 25MILKENINSTITUTEmilkeninstitute.orgVisit source
- Reference 26PSYCHIATRYpsychiatry.orgVisit source
- Reference 27ONSons.gov.ukVisit source
- Reference 28HEALTHDATAhealthdata.orgVisit source
- Reference 29APAapa.orgVisit source
- Reference 30ADAAadaa.orgVisit source
- Reference 31AARPaarp.orgVisit source
- Reference 32ILOilo.orgVisit source
- Reference 33HUDUSERhuduser.govVisit source
- Reference 34CENTREFORMENTALHEALTHcentreformentalhealth.org.ukVisit source
- Reference 35PRISONPOLICYprisonpolicy.orgVisit source
- Reference 36EUROCARERSeurocarers.orgVisit source
- Reference 37DELOITTEwww2.deloitte.comVisit source
- Reference 38IQVIAiqvia.comVisit source
- Reference 39NHSnhs.ukVisit source
- Reference 40NATUREnature.comVisit source
- Reference 41TREATMENTADVOCACYCENTERtreatmentadvocacycenter.orgVisit source
- Reference 42KFFkff.orgVisit source
- Reference 43NEJMnejm.orgVisit source
- Reference 44JOURNALSjournals.sagepub.comVisit source






